IPHA
Innate Pharma SA · NYSE EURONEXT - EURONEXT PARIS · Biotechnology
$1.35$-0.04 (-2.88%)
Prices delayed up to 5 minutes
AC Intelligence
AC Intelligence
AC Intelligence for IPHA is being prepared.
Key Stats
Key Stats
Open
$1.36
Day High
$1.37
Day Low
$1.32
Prev Close
$1.39
Volume
0
Avg Volume
266.4K
Day Change
$-0.04
Change %
-2.88%
Fundamentals
Fundamentals
P/B
18.20
EPS (TTM)
$-0.80
Market Cap
$109M
52-Wk Range
$1.03 — $2.10
Earnings History
Insider Activity
Who Owns This Stock
Who Owns IPHA
Other73.6%7 holders
Dealer / Bank17.1%2 holders
Tactical / Macro7.4%1 holder
Passive / Index1.9%1 holder
Based on Q4 2025 13F filings + AC behavioral model
11 institutional holders
Top Holders
$161.8B
$142.0B
$76.2B
$49.8B
$35.5B
$9.1B
$5.0B
-53.0%$1.9B
-82.4%$1.4B
$485M
-96.8%$256M
0.0%$18M
-99.7%$2M
$2M
Institutional Pressure
Market Regime:Strong Risk-Off (-0.62)SELLINGBUYING
▲
Mild Selling Pressure
Other(73.6%)
●
—Dealer / Bank(17.1%)
●
FacilitatingTactical / Macro(7.4%)
◄◄
Reducing rapidlyPassive / Index(1.9%)
●
Holds2% passive + quality floor won't sell.
Updated daily · Based on Q4 2025 filings + AC behavioral model
Sentiment Signals
Sentiment Signals
→Insider ActivityNo insider transactions in last 90 daysSEC Form 4
↑↑Analyst Consensus7 buy, 1 hold, 0 sellFinnhub
↑↑Inst. Flows9 increased/new, 4 decreased/exited (13F)AC 13F Analysis
Sources: SEC Form 4, Finnhub, AC 13F Analysis
On AcidCapitalist
On AcidCapitalist
No recent mentions of IPHA on AcidCapitalist.
Data provided by Finnhub. Prices delayed up to 5 minutes.